Novel drug delivery system mainly consents about achieving the targeted concentration to release the drug at targeted site by using carrier system, altering the structure and microenvironment around the drug. Especially drugs which are having narrow therapeutic window are difficult to formulate, with the advantage of novel drug delivery systems like particulate, polymeric carrier, macromolecular and cellular carriers. They are used to reduce complications as well as release the drug in a determined fusion at targeted site. In vesicular drug delivery system drug binds covalently to the lipid molecule by which the drug release is in a controlled manner and also drugs which are of hydrophilic or lipophilic nature can be delivered by using vesicular drug delivery systems. The release of drug from the vesicles depends on the physicochemical properties of both the drug and carrier. Vesicular drug delivery includes liposomes, niososmes, transferosomes, pharmacosomes, electrosomes, ethosomes etc. Of all these drug delivery systems pharmacosomes are having more advantages like no leakage or loss of drug, stability, high entrapment efficiency etc, pharmacosomes may be hexagonal aggregates , ultrafine vesicular and micellar forms. Both synthetic and natural drugs which are facing difficulties like low solubility and low permeability can be effectively formulated and can achieve required pharmacokinetic and pharmacodynamic parameters. Pharmacosomes are prepared by hand shaking method, ether injection, solvent evaporation method, anhydrous co-solvent lyophilyzation, supercritical fluid approach and other alternative methods they are characterized by complex determination, surface morphology, drug entrapment, solubility, drug lipid compatibility, crystal state measurement, dissolution studies and in vitro drug release rate.
INTRODUCTION
Novel drug delivery system (NDDS) primarily focuses on formulation, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. Safely novel drug delivery is far better than the conventional dosage form. Novel drug delivery system should full fill the following requirements:
 Firstly, it delivers specific amount of drug at a rate directed by the needs of the body, over the period of treatment.
 Secondly, it delivers the active drug moiety to the targeted site of action. 1
Advantages of novel drug delivery systems
 Optimal dose at the right time and right location  Efficient use of expensive drugs and excipients  Cost efficient and also show more benefits than other novel drug delivery systems.


Better therapy and improved comfort and standard of living

The adverse effects and also toxic effects are minimized Basic modes of novel drug delivery system are:
1. Targeted drug delivery system.
2. Controlled drug delivery system.
Modulated drug delivery system.
Vesicular drug delivery systems
Nowadays vesicular drug delivery is one of the advanced novel drug delivery system. Biological origins of the vesicles were first reported by the Bingham in year of 1965, so they termed as "Bingham bodies". 2 From the past few years, vesicles have evolved by the vehicle of choice in novel drug delivery. Vesicular drug delivery has immense worth in genetic engineering, immunological, membrane, biological and diagnostic techniques. Vesicular drug delivery plays a vital role in modeling membrane as well as in the targeting and delivery of active principle. 3 Drug carriers are the substance which used in the process of drug delivery and they help to improve the drug effectiveness, selectivity, and/or safety in administration of drug.
Drug carriers release the drug in systemic circulation in a controlled manner. This can be attained either by slow release of drug over a long period of time or by actuated release at the drug target by some stimulants such as changes in pH, application of heat, and activation by light. Especially, in the case of drugs with poor water solubility and/or membrane permeability, drug carriers are used to improve their pharmacokinetic and the bioavailability. 4 Liposomes consist of either natural or synthetic phospholipids. 5 They consist of hydrophilic, lipophilic and amphiphilic moieties which help in accommodation of the drug molecule having a wide array of solubility. These vesicles are variable and controllable and their properties can be supervised by modifying the vesicle structure, size, lamellarity, tapped density, surface charge and concentration. It can be a depository and release drug in a controlled way. 6 The  Vesicular drug delivery is an efficacious method for reducing the drug toxicity and targeting to the site of action.

This system improves the bioavailability principally in case of the poorly aqueous soluble drugs.
In this systems both the hydrophilic and lipophilic drugs are embodied.
It sustains the release of drugs by delaying the time of elimination through they are rapidly metabolizable. 8  They overcoming the problems regarding stability, solubility and degradation of the drug.
The limitations of conventional dosage forms can be triumph by acting as drug reservoir by encapsulating the drug.
The carriers of the vesicular drug delivery system are biocompatible and biodegradable as they are similar to biomolecular functions and structure.
 Vesicular systems are associated with some complications of drug carrier such as particulates and loading of drug passively, which may lead to decrease in drug loading efficiency and leakage of drug during formulation, storage and delivery in vivo . 9
Pharmacosomes:
Pharmacosomes are part of the novel drug delivery system. They were first introduced by vaizoglu and Speriser in 1968. 10 Pharmacosomes are determined as the colloidal dispersions, drugs covalently bound to the lipids, and may exists as ultra fine vesicular, micellar, or hexagonal aggregates, on the basis of the chemical structure of the drug-lipid complex. [10, 11] The system is composed by linking a drug (pharmakon) to a carrier (soma), so they termed as "Pharmacosomes". 

The drug-lipid complex depends upon the phase transition temperature but independent on rate of release as it is covalently bounded to the lipid.
 No leaching will occur as drug is bounded to the lipid by covalent bonding.
 Delivers drug at the specific site and site targeted.
 By enzymatic methods like hydrolysis drug is released from the lipid polymer.
The metabolism of the drug depends on the spacer, length of chain in lipid, functional groups and size of the drug during its absorption.
They reduce the cost of therapy.
 They are suitable for the both lipophilic and hydrophilic drugs.
The aqueous solution of the amphiphiles exhibits concentration dependant aggregation.
The drug and carrier are covalently linked together so, entrapment efficiency is high and predetermined.
 Drug release of pharmacosomes is by hydrolysis.
 They improves the bioavailability majorly incase of poorly soluble drugs.
 They reduce the adverse effects and toxicity.
In pharmacosomes, there is no need to remove the unentrapped drug when compared to liposomes where the free drug should be removed  Drugs like bupranolol hydrochloride, pindolol maleate, acyclovir, taxol, etc by using of pharmacosomes drug delivery has therapeutic performance has been improved. 9 
Salient features of pharmacosomes:
 Pharmacosomes can be administered in various route such as orally, extra vascular and intravascular.

The drug conjugates with lipids and results in high entrapment efficacy in predetermined fashion.
There is no problem when the drug is incorporated into the lipid.
 They consist of both hydrophilic and lipophilic properties so they can easily pass through the cell membrane, walls, or tissues either by action of endocytosis or exocytosis.
The physicochemical characters of the drug-lipid complex affect the stability of pharmacosomes.
Limitations of pharmacosomes:
 Amphiphilicity is required in the compound.

Both the surface and bulk interaction may be observed.
 Drug should be covalently bounded to the lipid.
Components of pharmacosomes:
The components for pharmacosomes preparation are: Drug, Solvent and Lipid.
Drugs
Any drug containing active hydrogen atom (-COOH, -OH, -NH2, etc) can be esterified with the lipid, with or without spacer chain. Facilitates membrane, tissue, cell wall transfer in the organisms is due to its amphiphilic nature.
Solvents
They should be high pure and volatile in nature, and should be selected based on the intermediate polarity for their preparations.
Lipids  Phospholipids are the major components of biological membrane; majorly two types of phospholipids are used namely phosphoglycerides and sphingolipids.

The most common type of phospholipids is Phosphotidylecholine moiety.
Phosphotidylecholine is an amphiphilic molecule in which a glycerol bridges links a pair of hydrophobic acylhydrocarbon chains with hydrophilic polar head group phosphocholine. 13 Applications of phosphotidylecholine  Phosphotidylecholine place a vital role in supporting cell membrane integrity and basic biological process.
 Impairment of cell membrane and its repair which results in liver disorders can be managed and also acts as a hepato-protective agent by acting as supplement source of choline.
 It can also promote breakdown of collagen and prevent fibrosis and cirrhosis. 
Preparation of pharmacosomes:
There are two methods which have been employed to prepare pharmacosomes;
1) Hand-shaking method

In the hand-shaking method, both the drug and lipid shell be mixed in the round bottomed flask.
The organic solvent is evaporated by using rotary vaccum evaporator at room temperature, results in formation of a thin film of deposition on the walls.
The dried film is then hydrated with buffer and rotated in one direction with hand which results in the formation of vesicular suspension. [13] 2) Ether injection method  The drug-lipid complex is dissolved in specified volume of ether.
Then the above mixture is slowly injected into a heated buffer solution, resulting in the formation of the vesicles.
The nature of vesicle especially the shape depends on the concentration.
The variety of structures may be formed that are, round, cylindrical, disc, cubic, or hexagonal type depending on the amphiphilic state. 
The turbulent flow of solvent and carbon dioxide results in fast mixing of dispersion leading to the formation of pharmacosomes.
5) Solvent evaporation method

In the solvent evaporation method of preparing the pharmacosomes, the drug is first acidified so that the active hydrogen might be available for complexation.
The drug acid is then extracted into chloroform and subsequently recrystallized. The drug-PC complex is prepared by associating drug acid with PC in various molar ratios.
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
The mixture is refluxed for one hour. Then the solvent is evaporated off under vacuum at 40 ° C in a rotary vacuum evaporator.
The dried residues are then collected and placed in vacuum desiccator for complete drying. 
6) Recent approaches
Characterization of pharmacosomes 1) Complex determination
Using correlation spectrum the formation of both conjugate and complex can be contingent upon inspecting with that of discrete constituents and also with their mixture using FTIR spectrum. 19 
2) Surface morphology
The surface morphology can be predicted using Scanning Electron Microscopy (SEM) or Transmission Electron Microscopy (TEM). The shape and size of pharmacosomes are prone to variations by some variables such as rotation speed, vaccum applied, Purity grade of phospholipids or the method used.
3) Drug entrapment
To know the amount of drug present in the drug complex estimated quantity of pharmacosomes were transferred into a suitable flask containing known volume of solvent in which drug is soluble. Mix the above contents thoroughly or sonicate, leave the contents for 24 hrs without disturbing and estimate the dug present by using UV spectroscopy or HPLC.
4) Solubility
Solubility is determined by placing the known amount of phospholipid complex in a screw caped penicillin bottle containing aqueous phase buffer solution of varying pH (2-7.4) and organic phase like 1-Octonol with continuous shaking at a temperature of 37 ο c for 24hrs. Then both the layers will be separated and samples were analyzed using HPLC or UV spectrophotometer 20 
5) Drug lipid compatibility
Differential scanning electron microscopy is a thermo analytical technique used to determine drug-lipid compatibility and their interactions. Thermal response is studied by using separate sample and heating them in a sample pan, which is closed. The nitrogen gas is plugged, and the temperature is maintained in a definite range with a specific heating rate.
6) Crystal state measurement
The crystal nature of the drug can be determined by using Xray diffraction technique. The tube voltage and tube current can be regulated in the X-ray generator. Copper lines may be used as the source of radiations. The overall integrated intensity of all reflection peaks are projected by area under curve of X-ray diffraction pattern that specifies the specimen characteristics. 21 
7) Dissolution studies
Dissolution studies in vitro are done by using various models available using different buffers, then the results obtained are estimated on the basis of activity of the drug. 22 
8) In vitro drug release rate
The in vitro drug release rate is estimated by reverse dialysis bag technique. In this method pharmacosomes are introduced inside the dialysis bag and the receiver phase is placed outside. Dialysis bag containing the continuous phase and they are suspended in a vessel containing the donor phase and stirred at predetermined time intervals, each dialysis bag is removed and the contents are analyzed for drug release. An advantage of this technique is increase in the membrane surface area available for transport from the donor to receptor compartment. Another advantage of this technique is the increased efficiency in terms of staffing as a consequence of reduction in number of steps. 21 
Applications of pharmacosomes

Pharmacosomes possess better stability and shelf life compared to other vesicular drug delivery systems.
 Absorption and permeation of the drug can be enhanced formulating in to pharmacosomes.
The transportation of drug across the biological membranes is due to the vesicular formation as they have the capacity to interact with the membranes, due to their transitions from vesicle to micelle by altering the transition temperature  By altering the temperature at the targeting site pharmacosomes have the capacity to deliver the drug in the targeted site especially in the case of cell specific drug vehicles.
 Pindolol diglyceride, Amoxicillin, Taxol, Cytrabine, Dermatansulfate, Bupranolol hydrochloride etc showed increase in pharmacological action by formulating into pharmacosomes.
The mechanism of action of drugs and non bilayer phases can be studied by using pharmacosomes.
 PEGylation and biotinyzation are used in current research in the production of pharmacosomes.  Pharmacosomes employed to prepare Tetrahydrofuran injection method and studied in the in-vitro behavior in rats for didanosine, by which they observed that pharmacosomes possess prolonged action in both targeted site and liver. 26  Pharmacosomes formulated using 3, 5-dioctanoyl-5-fluro-2-deoxyuridine with a central composite design resulted in formation of regulated pharmacosomes, shows a great targeting efficiency in both in-vitro and enhanced drug capacity to pass through blood brain barrier. 27  The suppression in hemolytic reaction of pharmacosomes of acyclovir by noticing the interaction of pharmacosomes with erythrocytes and plasma proteins after absorption. 28  Improved bioavailability and reduced gastrointestinal toxicity in aspirin was predicted by preparing aspirin phospholipid complex. 29 
CONCLUSION
In pharmacosomes drug is bound to the polymer by covalent, van der Waal and hydrogen bonding. The drug will be released will by hydrogen bonding. Pharmacosomes achieve desired dose by drug targeting in controlled release. The pro-drugs can be amalgamated acquiring amphiphilic in nature. Both the lipophilic and hydrophilic drugs can be suitable candidates, by covalent bonding with the polymer shows increase in entrapment efficiency. Pharmacosomes reduce toxicity and can improve therapeutic performance of drug. A biodegradable micelle forming drug conjugates increasing hydrophilicity of drug, Whereas change in the ratio of polymers show enhance cytoprotection by formulation of "vesicular constructs "using aqueous domain . 
